RLMD
USDRelmada Therapeutics Inc. Common Stock
$2.770+0.560 (25.339%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$2.210
最高
$2.810
最低
$2.190
交易量
0.98M
公司基本面
市值
91.9M
行業
生物科技
國家
United States
交易統計
平均交易量
0.74M
交易所
NCM
貨幣
USD
52週範圍
最低 $0.24當前 $2.770最高 $3.5
相關新聞
GlobeNewswire
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and
查看更多
GlobeNewswire
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized
查看更多
